Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases

Clinical trial NCT00811174 · TERMINATED

Trial details

NCT number: NCT00811174
Sponsor: Octapharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunologic Deficiency Syndromes

Start date: 2009-01-01
Primary completion: 2010-09-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.